Prostatic Neoplasms - Mortality
Research News and Information

Saturday, November 21, 2009

A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.

26 Sep 2009 BACKGROUND: Information is needed to aid individual decision making about prostate-specific antigen (PSA) screening. METHODS: We aimed to provide such information for men aged 40, 50, 60, and 70 years at low, moderate, and high risk for prostate ... Read more...

Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras.

14 Sep 2009 PURPOSE: We clarified whether men older than 70 years have a higher risk of prostate cancer and poorer survival in the early and late prostate specific antigen eras. MATERIALS AND METHODS: A cohort of 4,561 men who underwent radical prostatectomy ... Read more...

Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database.

14 Sep 2009 PURPOSE: We examined natural history, predictors of biochemical recurrence and all cause mortality in patients with persistently elevated prostate specific antigen after radical prostatectomy in the Shared Equal Access Regional Cancer Hospital ... Read more...

Latest indexed articles for 'Prostatic Neoplasms - Mortality'

These are the very latest articles for this heading:

• Prostate cancer screening and surveillance. 12 Oct 2009
• First do no harm. 29 Sep 2009
• A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices. 26 Sep 2009
• Weighing the benefits and downsides of prostate-specific antigen screening. 26 Sep 2009
• Screening for prostate cancer remains controversial. 22 Sep 2009
• Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial I. M. Thompson, C. M. Tangen, J. Paradelo, M. S. Lucia, G. Miller, D. Troyer, E. Messing, J. Forman, J. Chin, G. Swanson, E. Canby-Hagino and E. D. Crawford J Urol 2009; 181: 956-962. 16 Sep 2009
• Editorial comment. 14 Sep 2009
• Editorial comment. 14 Sep 2009
• Editorial comment. 14 Sep 2009
• Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras. 14 Sep 2009
• Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database. 14 Sep 2009
• Outcomes of localized prostate cancer following conservative management. 14 Sep 2009
• Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. 7 Sep 2009
• An iatrogenic confounding variable. 7 Sep 2009
• PSA testing in Austria: induced morbidity and saved mortality. 30 Aug 2009
• Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study. 30 Aug 2009
• Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A(2)beta in prostate cancer cells. 30 Aug 2009
• Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival. 30 Aug 2009
• External-beam radiotherapy for clinically localized prostate cancer in Osaka, Japan, 1995-2006: time trends, outcome, and risk stratification. 26 Aug 2009
• Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy. 26 Aug 2009

See a longer list of these articles.

Technical information about 'Prostatic Neoplasms'

Definition: Tumors or cancer of the PROSTATE.

Descriptor UI: D011471

Alternative terms: Prostatic Neoplasms; Neoplasms, Prostate; Neoplasm, Prostate; Prostate Neoplasm; Neoplasms, Prostatic; Neoplasm, Prostatic; Prostatic Neoplasm; Prostate Neoplasms; Prostate Cancer; Cancer, Prostate; Cancers, Prostate; Prostate Cancers; Cancer of the Prostate; Prostatic Cancer; Cancer, Prostatic; Cancers, Prostatic; Prostatic Cancers; Cancer of Prostate;

Related Mesh Headings: Prostatic Hyperplasia; Prostate-Specific Antigen;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.945.440.770; C12.294.260.750; C12.294.565.625; C12.758.409.750;

Technical Notes: coordinate IM with histological type of neoplasm (IM); note PROSTATIC ADENOMA see PROSTATIC HYPERPLASIA is also available